115 related articles for article (PubMed ID: 17977676)
1. The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo.
Hirano T; Yasuda S; Osaka Y; Asari M; Kobayashi M; Itagaki S; Iseki K
Int J Pharm; 2008 Mar; 351(1-2):113-8. PubMed ID: 17977676
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells.
Hirano T; Yasuda S; Osaka Y; Kobayashi M; Itagaki S; Iseki K
Biochim Biophys Acta; 2006 Nov; 1758(11):1743-50. PubMed ID: 16928358
[TBL] [Abstract][Full Text] [Related]
3. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells.
Rytting E; Audus KL
J Pharm Pharmacol; 2007 Aug; 59(8):1095-102. PubMed ID: 17725851
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta.
Karahoda R; Ceckova M; Staud F
Toxicol Appl Pharmacol; 2019 Apr; 368():18-25. PubMed ID: 30735677
[TBL] [Abstract][Full Text] [Related]
5. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Ohashi R; Tamai I; Yabuuchi H; Nezu JI; Oku A; Sai Y; Shimane M; Tsuji A
J Pharmacol Exp Ther; 1999 Nov; 291(2):778-84. PubMed ID: 10525100
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
7. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells.
Rytting E; Audus KL
J Pharmacol Exp Ther; 2005 Jan; 312(1):192-8. PubMed ID: 15316089
[TBL] [Abstract][Full Text] [Related]
8. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
[TBL] [Abstract][Full Text] [Related]
9. Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla.
Cano MM; Calonge ML; Ilundain AA
J Cell Physiol; 2010 May; 223(2):451-9. PubMed ID: 20112288
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes.
Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T
J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668
[TBL] [Abstract][Full Text] [Related]
11. Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta.
Grube M; Meyer Zu Schwabedissen H; Draber K; Präger D; Möritz KU; Linnemann K; Fusch C; Jedlitschky G; Kroemer HK
Drug Metab Dispos; 2005 Jan; 33(1):31-7. PubMed ID: 15486076
[TBL] [Abstract][Full Text] [Related]
12. Carnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+/+)) and OCTN2 Null (OCTN2(-/-)) Mice.
Shekhawat PS; Yang HS; Bennett MJ; Carter AL; Matern D; Tamai I; Ganapathy V
Pediatr Res; 2004 Sep; 56(3):323-8. PubMed ID: 15240869
[TBL] [Abstract][Full Text] [Related]
13. L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2.
Lahjouji K; Elimrani I; Lafond J; Leduc L; Qureshi IA; Mitchell GA
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C263-9. PubMed ID: 15238359
[TBL] [Abstract][Full Text] [Related]
14. Functional activity of L-carnitine transporters in human airway epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2016 Feb; 1858(2):210-9. PubMed ID: 26607009
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-mediated down-regulation of OCTN2 and PPARα expression in human placentas and in BeWo cells.
Chang TT; Shyu MK; Huang MC; Hsu CC; Yeh SY; Chen MR; Lin CJ
Mol Pharm; 2011 Feb; 8(1):117-25. PubMed ID: 21125992
[TBL] [Abstract][Full Text] [Related]
16. Regulation of protein expression and function of octn2 in forskolin-induced syncytialization in BeWo Cells.
Huang FD; Kung FL; Tseng YC; Chen MR; Chan HS; Lin CJ
Placenta; 2009 Feb; 30(2):187-94. PubMed ID: 19091402
[TBL] [Abstract][Full Text] [Related]
17. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
18. Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).
Srinivas SR; Prasad PD; Umapathy NS; Ganapathy V; Shekhawat PS
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1046-53. PubMed ID: 17855766
[TBL] [Abstract][Full Text] [Related]
19. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
Watanabe C; Kato Y; Sugiura T; Kubo Y; Wakayama T; Iseki S; Tsuji A
Drug Metab Dispos; 2006 Nov; 34(11):1927-34. PubMed ID: 16896066
[TBL] [Abstract][Full Text] [Related]
20. Maternal Plasma l-Carnitine Reduction During Pregnancy Is Mainly Attributed to OCTN2-Mediated Placental Uptake and Does Not Result in Maternal Hepatic Fatty Acid
Bai M; Zeng Q; Chen Y; Chen M; Li P; Ma Z; Sun D; Zhou H; Zheng C; Zeng S; Jiang H
Drug Metab Dispos; 2019 Jun; 47(6):582-591. PubMed ID: 30918014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
